Company Filing History:
Years Active: 2014
Title: Inventor Punit Kumar Sricastava: A Pioneer in Matrix Metalloproteinase Inhibitors
Introduction
Punit Kumar Sricastava, based in Gurgaon, India, is a notable inventor renowned for his contributions to the field of pharmaceutical sciences. He holds one patent, which focuses on matrix metalloproteinase inhibitors. His innovative work in this area provides significant implications for treating various inflammatory and autoimmune diseases.
Latest Patents
Sricastava's patent centers around the development of β-hydroxy and amino-substituted carboxylic acids that serve as matrix metalloproteinase inhibitors. The invention discusses diastereomerically pure β-hydroxy carboxylic acids, their synthesis processes, and pharmaceutical compositions that incorporate these compounds. This invention is particularly valuable in addressing medical conditions such as asthma, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and other inflammatory disorders that arise from the over-expression and over-activation of matrix metalloproteinases.
Career Highlights
Punit Kumar Sricastava is currently associated with Ranbaxy Laboratories, Inc., where he works on advancing pharmaceutical innovations. His focus on matrix metalloproteinase inhibitors showcases his commitment to developing effective treatments for complex diseases, thereby enhancing patient care and offering new therapeutic avenues.
Collaborations
Throughout his career, Sricastava has collaborated with esteemed colleagues, including Viswajanani Jitendra Sattigeri and Venkata Poornapragnacharyulu Palle. These collaborations emphasize the importance of teamwork in scientific research, driving advancements in innovation and therapeutic development.
Conclusion
In conclusion, Punit Kumar Sricastava is a significant figure in the realm of pharmaceutical inventions, particularly with his patent on matrix metalloproteinase inhibitors. His work not only contributes to the scientific community but also holds promise for those suffering from various inflammatory and autoimmune diseases. As a member of Ranbaxy Laboratories, Inc., Sricastava continues to push the boundaries of innovation in medicine, demonstrating the critical role of inventors in improving healthcare outcomes.